Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2019

View Archived Issues

Microglia and AD

BRCA's effects range from indispensable to indifferent

Mimicking bone marrow keeps cultured blood stem cells quiescent

Polyphor closes phase III PRISM studies of murepavadin intravenous formulation

Positive topline data presented from phase IIb study of the TLPLDC vaccine

Recruitment ongoing in phase I/II study of FT-4101 in overweight/obese subjects with NASH

Tipepidine shows promise as a supplementary medication in children with ADHD

PledPharma reports results from POP phase I trial of calmangafodipir for paracetamol overdose

Results of exploratory analysis based on tumor location from phase II REACHIN study of regorafenib

Anti-SEMA4D antibody VX-15 may offer therapeutic potential for Alzheimer's disease

Intracutaneous zolmitriptan given high Migraine-ACT scores in clinical trial

Researchers test intranasal dantrolene for the treatment of Alzheimer's disease

X4 Pharmaceuticals patents CXCR4 antagonists

Bellus Health initiates phase II trial of BLU-5937 for unexplained or refractory chronic cough

Sterngreene presents new EGFR and HER2 inhibitors

Cyclerion Therapeutics synthesizes sGC activators

Presentation of data for PLX-R18 as prophylactic countermeasure for ARS

WHO declares Ebola outbreak in DRC a public health emergency of international concern

ChemoCentryx describes C5aR antagonists

Ribon Therapeutics discovers PARP14 inhibitors

Seelos submits IND for phase IIb/III study of SLS-005 for Sanfilippo syndrome

Cognitive and motor function enhanced by ASKT-4290 in aged mice

Apellis to develop APL-9 to target host responses to AAV vector administration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...